Inventaire - your friends and communities are your best library

IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection

author

Stefan Zeuzem

Elke Verheij-Hart

Jean-Michel Pawlotsky

1961 -

Martin Lagging

Gabriele Missale

Carlo Ferrari

1957 -

Bart L. Haagmans

1963 -

Kristoffer Hellstrand

Johan Westin

Solko W Schalm

Gunnar Norkrans

Amar P. Dhillon

Avidan Neumann

published in: Hepatology

date of publication: 2006-12

language: English

main subject: patient

Cites articles 20

Date

Title

Authors

2006-03

Association of pretreatment serum interferon inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C
2005-01-01

Early viral kinetics and treatment outcome in combination of high-dose interferon induction vs. pegylated interferon plus ribavirin for naive patients infected with hepatitis C virus of genotype 1b and high viral load

Tetsuya Hosaka, Hiromitsu Kumada, Fumitaka Suzuki, Kenji Ikeda, Masahiro Kobayashi, Yoshiyuki Suzuki, Norio Akuta, Yasuji Arase, Satoshi Saito, Takashi Someya
2005-08-15

Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C

Adrian M. Di Bisceglie, Charles M. Rice
2005-08-01

International, multicenter, randomized, controlled study comparing dynamically individualized versus standard treatment in patients with chronic hepatitis C.

Jean-Michel Pawlotsky, Martin Lagging, Bettina Hansen, Carlo Ferrari, Stefan Zeuzem, Elke Verheij-Hart, DITTO-HCV Study Group, Solko W Schalm, Yoav Lurie, Esther Lukasiewicz, Christophe Hézode, Ioannis Goulis, Avidan Neumann
2004-03-02

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose
2003-11-25

Predicting the therapeutic response in patients with chronic hepatitis C: the role of viral kinetic studies
2003-09-01

Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation

Jeffrey John Post, Rakesh K. Kumar, Andrew R. Lloyd
2003-09-01

Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C.

Michael Manns
2002-09-26

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

Giampiero Carosi, Antonio Craxì, K. Rajender Reddy, Dieter Häussinger
2002-04-01

Progression of fibrosis in untreated patients with hepatitis C virus infection

Martin Lagging, Magnus Lindh
2002-05-01

Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection

Martin Lagging, Amar P. Dhillon
2002-12-01

Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients

Martin Lagging
2001-09-22

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Michael Manns
2000-12-01

Peginterferon alfa-2a in patients with chronic hepatitis C.
2000-03-01

Distinct patterns of stimulus-inducible chemokine mRNA accumulation in human fetal astrocytes and microglia
1999-06-01

Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection

Martin Lagging
1997-09

The immunobiology of interferon-gamma inducible protein 10 kD (IP-10): a novel, pleiotropic member of the C-X-C chemokine superfamily
1995-06

Histological grading and staging of chronic hepatitis
1993-06-01

Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells

Andrew R. Lloyd
1985-06

Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins

Article - wd:Q28276247

Welcome to Inventaire

the library of your friends and communities

learn more